General MedicationsORALStandard
DAYBUE STIX
TROFINETIDE
Standard Dose
8000MG/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DAYBUE STIX is listed in Drugs@FDA under application 219884 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TROFINETIDE Form and strength FOR SOLUTION;ORAL - 8000MG/PACKET Sponsor ACADIA PHARMS INC Submission history Latest submission status date: 2025-12-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview DAYBUE STIX is listed in Drugs@FDA under application 219884 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TROFINETIDE Form and strength FOR SOLUTION;ORAL - 8000MG/PACKET Sponsor ACADIA PHARMS INC Submission history Latest submission status date: 2025-12-11 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.